EE141 Cost-Effectiveness of Pembrolizumab for Adjuvant Treatment of Patients With Renal-Cell Carcinoma Who Have Undergone Nephrectomy in Colombia
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.440
https://www.valueinhealthjournal.com/article/S1098-3015(24)00555-2/fulltext
Title :
EE141 Cost-Effectiveness of Pembrolizumab for Adjuvant Treatment of Patients With Renal-Cell Carcinoma Who Have Undergone Nephrectomy in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00555-2&doi=10.1016/j.jval.2024.03.440
First page :
Section Title :
Open access? :
No
Section Order :
11787